Verve Therapeutics, Inc.
VERVDelisted Jul 25, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001840574
Verve Therapeutics, Inc. was delisted on Jul 25, 2025; its insiders filed their last Form 4 on Jul 28, 2025; 176 institutions reported holding it in 13F filings for Q2 2025, worth $819.4M in total; no superinvestor held it.
Q4 2021 vs. Q3 2021
How the institutions holding Verve Therapeutics, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 73 | 96 | +23 |
| Shares | 38.7M | 45.2M | +6.44M (+16.6%) |
| Value | $1.81B | $1.66B | −$150.8M (−8.3%) |
New holders (33)
Institutions that held Verve Therapeutics, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
Sold out (10)
Institutions that held Verve Therapeutics, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Caas Capital Management LP | 15,000 | $705.0K |
| Ghisallo Capital Management LLC | 15,000 | $705.0K |
| Mirabella Financial Services LLP | 14,320 | $673.0K |
| Cinctive Capital Management LP | 12,000 | $564.0K |
| CIBC World Markets Inc. | 9,239 | $434.0K |
| SG Americas Securities, LLC | 7,015 | $330.0K |
| Cubist Systematic Strategies, LLC | 6,406 | $301.0K |
| Blair William & Co | 4,875 | $229.0K |
| Captrust Financial Advisors | 64 | $3.00K |
| Red Tortoise LLC | 94 | $3.00K |